Literature DB >> 18647794

The role of cognitive functioning in medication adherence of children and adolescents with HIV infection.

Kathleen Malee1, Paige L Williams, Grace Montepiedra, Sharon Nichols, Patricia A Sirois, Deborah Storm, John Farley, Betsy Kammerer.   

Abstract

OBJECTIVE: To evaluate the relationship between cognitive functioning and medication adherence in children and adolescents with perinatally acquired HIV infection.
METHODS: Children and adolescents, ages 3-18 (N = 1,429), received a cognitive evaluation and adherence assessment. Multiple logistic regression models were used to identify associations between adherence and cognitive status, adjusting for potential confounding factors.
RESULTS: Children's average cognitive performance was within the low-average range; 16% of children were cognitively impaired (MDI/FSIQ <70). Cognitive status was not associated with adherence to full medication regimens; however, children with borderline/low average cognitive functioning (IQ 70-84) had increased odds of nonadherence to the protease inhibitor class of antiretroviral therapy. Recent stressful life events and child health characteristics, such as HIV RNA detectability, were significantly associated with nonadherence.
CONCLUSION: Cognitive status plays a limited role in medication adherence. Child and caregiver psychosocial and health characteristics should inform interventions to support adherence.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18647794      PMCID: PMC2722123          DOI: 10.1093/jpepsy/jsn068

Source DB:  PubMed          Journal:  J Pediatr Psychol        ISSN: 0146-8693


  30 in total

1.  Effect of combination therapy including protease inhibitors on mortality among children and adolescents infected with HIV-1.

Authors:  S L Gortmaker; M Hughes; J Cervia; M Brady; G M Johnson; G R Seage; L Y Song; W M Dankner; J M Oleske
Journal:  N Engl J Med       Date:  2001-11-22       Impact factor: 91.245

2.  School-age children with perinatally acquired HIV infection: medical and psychosocial issues in a Philadelphia cohort.

Authors:  E Mialky; J Vagnoni; R Rutstein
Journal:  AIDS Patient Care STDS       Date:  2001-11       Impact factor: 5.078

3.  Adherence to medication regimens among children with human immunodeficiency virus infection.

Authors:  C Reddington; J Cohen; A Baldillo; M Toye; D Smith; C Kneut; A Demaria; J Bertolli; H W Hsu
Journal:  Pediatr Infect Dis J       Date:  2000-12       Impact factor: 2.129

4.  Reported adherence as a determinant of response to highly active antiretroviral therapy in children who have human immunodeficiency virus infection.

Authors:  Russell B Van Dyke; Sophia Lee; George M Johnson; Andrew Wiznia; Kathleen Mohan; Kenneth Stanley; Edward V Morse; Paul A Krogstad; Sharon Nachman
Journal:  Pediatrics       Date:  2002-04       Impact factor: 7.124

Review 5.  Children and adolescents living with HIV and AIDS: a review.

Authors:  L K Brown; K J Lourie; M Pao
Journal:  J Child Psychol Psychiatry       Date:  2000-01       Impact factor: 8.982

6.  Children of mothers with HIV/AIDS: unmet needs for mental health services.

Authors:  Laurie J Bauman; Ellen J Silver; Barbara H Draimin; Jan Hudis
Journal:  Pediatrics       Date:  2007-10-22       Impact factor: 7.124

7.  Longitudinal improvement in psychomotor processing speed is associated with potent combination antiretroviral therapy in HIV-1 infection.

Authors:  Stephen J Ferrando; Judith G Rabkin; Wilfred van Gorp; Shu-Hsing Lin; Martin McElhiney
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

8.  A family group approach to increasing adherence to therapy in HIV-infected youths: results of a pilot project.

Authors:  Maureen E Lyon; Connie Trexler; Carleen Akpan-Townsend; Maryland Pao; Keith Selden; Jean Fletcher; Irene C Addlestone; Lawrence J D'Angelo
Journal:  AIDS Patient Care STDS       Date:  2003-06       Impact factor: 5.078

9.  Adherence to prescribed antiretroviral therapy in human immunodeficiency virus-infected children in the PENTA 5 trial.

Authors:  Diana M Gibb; Ruth L Goodall; Vania Giacomet; Laura McGee; Alex Compagnucci; Hermione Lyall
Journal:  Pediatr Infect Dis J       Date:  2003-01       Impact factor: 2.129

10.  The relationship between stressful life events and cognitive function in HIV-infected men.

Authors:  Nicole D Pukay-Martin; Sarah A Cristiani; Radu Saveanu; Robert A Bornstein
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2003       Impact factor: 2.198

View more
  29 in total

1.  Discordance of cognitive and academic achievement outcomes in youth with perinatal HIV exposure.

Authors:  Patricia A Garvie; Bret Zeldow; Kathleen Malee; Sharon L Nichols; Renee A Smith; Megan L Wilkins; Paige L Williams
Journal:  Pediatr Infect Dis J       Date:  2014-09       Impact factor: 2.129

2.  Relationships between markers of vascular dysfunction and neurodevelopmental outcomes in perinatally HIV-infected youth.

Authors:  Suad Kapetanovic; Erin Leister; Sharon Nichols; Tracie Miller; Katherine Tassiopoulos; Rohan Hazra; Harris A Gelbard; Kathleen M Malee; Betsy Kammerer; Armando J Mendez; Paige L Williams
Journal:  AIDS       Date:  2010-06-19       Impact factor: 4.177

3.  Impact of HIV severity on cognitive and adaptive functioning during childhood and adolescence.

Authors:  Renee Smith; Miriam Chernoff; Paige L Williams; Kathleen M Malee; Patricia A Sirois; Betsy Kammerer; Megan Wilkins; Sharon Nichols; Claude Mellins; Ann Usitalo; Patricia Garvie; Richard Rutstein
Journal:  Pediatr Infect Dis J       Date:  2012-06       Impact factor: 2.129

4.  The HIV experience: youth identified barriers for transitioning from pediatric to adult care.

Authors:  Lori S Wiener; Brie-Anne Kohrt; Haven B Battles; Maryland Pao
Journal:  J Pediatr Psychol       Date:  2009-12-29

5.  Roles of Medication Responsibility, Executive and Adaptive Functioning in Adherence for Children and Adolescents With Perinatally Acquired HIV.

Authors:  Patricia A Garvie; Sean S Brummel; Susannah M Allison; Kathleen M Malee; Claude A Mellins; Megan L Wilkins; Lynnette L Harris; E Doyle Patton; Miriam C Chernoff; Richard M Rutstein; Mary E Paul; Sharon L Nichols
Journal:  Pediatr Infect Dis J       Date:  2017-08       Impact factor: 2.129

6.  International Congress of Drug Therapy in HIV Infection 23-26 October 2016, Glasgow, UK.

Authors: 
Journal:  J Int AIDS Soc       Date:  2016-10-23       Impact factor: 5.396

7.  Cognitive, academic, and behavioral correlates of medication adherence in children and adolescents with perinatally acquired HIV infection.

Authors:  Sharon L Nichols; Grace Montepiedra; John J Farley; Patricia A Sirois; Kathleen Malee; Betsy Kammerer; Patricia A Garvie; Sylvie Naar-King
Journal:  J Dev Behav Pediatr       Date:  2012-05       Impact factor: 2.225

8.  Social ecological predictors of longitudinal HIV treatment adherence in youth with perinatally acquired HIV.

Authors:  Sylvie Naar-King; Grace Montepiedra; Patricia Garvie; Betsy Kammerer; Kathleen Malee; Patricia A Sirois; Lisa Aaron; Sharon L Nichols
Journal:  J Pediatr Psychol       Date:  2013-04-28

9.  T-cell activation and neurodevelopmental outcomes in perinatally HIV-infected children.

Authors:  Suad Kapetanovic; Lisa Aaron; Grace Montepiedra; Sandra K Burchett; Andrea Kovacs
Journal:  AIDS       Date:  2012-05-15       Impact factor: 4.177

10.  Reproductive health decision-making in perinatally HIV-infected adolescents and young adults.

Authors:  Cynthia Fair; Lori Wiener; Sima Zadeh; Jamie Albright; Claude Ann Mellins; Michael Mancilla; Vicki Tepper; Connie Trexler; Julia Purdy; Janet Osherow; Susan Lovelace; Suad Kapetanovic
Journal:  Matern Child Health J       Date:  2013-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.